MEGANEST

Brand name authorized in: Spain

Active ingredients

The drug MEGANEST contains a combination of these active pharmaceutical ingredients (APIs):

1 Epinephrine
UNII 30Q7KI53AK - EPINEPHRINE BITARTRATE

Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation.

Read about Epinephrine
2 Articaine
UNII QS9014Q792 - ARTICAINE HYDROCHLORIDE

Articaine is a local anaesthetic of the amide type. Preclinical pharmacodynamic studies show that the mechanism of action of articaine is similar to that of other commonly used anaesthetics.

Read about Articaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Articaine, combinations
N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB58

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 61194, 61195